Area of research
Public Health, Environmental and Occupational Health · Infectious Diseases
Research interest
Research interests include Mosquito-borne diseases and control, Viral Infections and Vectors, Malaria Research and Control, and Viral Infections and Outbreaks Research.
Double-Antigen Lateral Flow Immunoassay for the Detection of Anti-HIV-1 and -2 Antibodies Using Upconverting Nanoparticle Reporters.
Enhanced cell density cultivation and rapid expression-screening of recombinant Pichia pastoris clones in microscale.
Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement.
<i>Cocculus hirsutus</i>
-derived phytopharmaceutical drug has potent anti-dengue activity
Tetravalent Dengue Vaccine in Healthy Children.
Dengue vaccine development: Global and Indian scenarios.
Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation.
Next generation designer virus-like particle vaccines for dengue.
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice
Evaluation of a pan-serotype point-of-care rapid diagnostic assay for accurate detection of acute dengue infection
Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies